KYMR — KYMERA THERAPEUTICS INC

Ownership history in Commodore Capital LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in KYMERA THERAPEUTICS INC (KYMR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.88% (2025 Q4)
Avg. % of fund
2.76%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 750,000 — 0% 3.88% $58.4M $77.81
2025 Q3 UNCHANGED 750,000 — 0% 2.07% $42.5M $56.60
2025 Q2 INITIATED 750,000 — — 2.31% $32.7M $43.64
% of Fund (quarterly)    KYMR price (monthly, adj. close)

Other funds also holding KYMR

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 41.91% BVF INC/IL 3Y 7Y 14.41% Siren, L.L.C. 7.63% Avoro Capital Advisors LLC 3Y 7Y 5.72% Octagon Capital Advisors LP 3Y 5.05% Monashee Investment Management LLC 3Y 7Y 4.38% BAKER BROS. ADVISORS LP 3Y 7Y 3.94% Eagle Health Investments LP 3Y 2.33% Patient Square Capital LP 3Y 2.32% Nan Fung Group Holdings Ltd 3Y 2.15%
← Back to Commodore Capital LP Holdings